Carsten Utoft Niemann (Carsten Niemann, Carsten U Niemann)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 87

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Davide Rossi, Thierry Soussi, Boris Tichy, Arnon P Kater, Carsten Utoft Niemann, Frederic Davi, Gianluca Gaidano, Stephan Stilgenbauer, Richard Rosenquist, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia 38 (7) (2024)
Petra Langerbeins, Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Othman Al-Sawaf, Anna-Maria Fink, Moritz Fürstenau, Nadine Kutsch, Florian Simon, Valentin Goede, Manuela A Hoechstetter, Carsten Utoft Niemann, Caspar da Cunha-Bang, Arnon P Kater, Julie Dubois, Michael Gregor, Philipp Bernhard Staber, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Barbara Eichhorst, Kirsten Fischer, Michael J Hallek
Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies. Blood (2024)
Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Davide Rossi, Thierry Soussi, Boris Tichy, Arnon P Kater, Carsten Utoft Niemann, Frederic Davi, Gianluca Gaidano, Stephan Stilgenbauer, Richard Rosenquist, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia 38 (7) (2024)
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia. Blood advances 8 (16) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Othman Al-Sawaf, Sandra Robrecht, Can Zhang, Stefano Olivieri, Yi Meng Chang, Anna-Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Karl-Anton Kreuzer, Liliya Sivcheva, Carsten Utoft Niemann, Anthony P Schwarer, Javier Loscertales, Robert Weinkove, Dirk Strumberg, Allanah Kilfoyle, Beenish S Manzoor, Dureshahwar Jawaid, Nnadozie Emechebe, Jacob Devine, Michelle Boyer, Eva D Runkel, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael J Hallek, Kirsten Fischer
Venetoclax-Obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the phase 3 CLL14 study. Blood (2024)
Rudi Agius, Anders C Riis-Jensen, Bettina Wimmer, Caspar da Cunha-Bang, Daniel Dawson Murray, Christian Bjørn Poulsen, Marianne B Bertelsen, Berit Schwartz, Jens Dilling Lundgren, Henning Langberg, Carsten Utoft Niemann
Deployment and validation of the CLL treatment infection model adjoined to an EHR system. NPJ digital medicine 7 (1) (2024)
Esben Packness, Olafur Birgir Davidsson, Klaus Rostgaard, Michael Asger Andersen, Emelie Curovic Rotbain, Carsten Utoft Niemann, Christian Brieghel, Henrik Hjalgrim
Infections and their prognostic significance before diagnosis of chronic lymphocytic leukemia, non-Hodgkin lymphoma, or multiple myeloma. British journal of cancer (2024)
Mehdi Parviz, Rudi Agius, Emelie Curovic Rotbain, Noomi Vainer, Kathrine Aarup, Carsten Utoft Niemann
Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning. Leukemia & lymphoma (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Tereza Faitová, Christian Brieghel, Frank Eriksson, Carsten Utoft Niemann
Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study. HemaSphere 8 (3) (2024)
Petra Langerbeins, Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Othman Al-Sawaf, Anna Maria Fink, Moritz Fürstenau, Nadine Kutsch, Florian Simon, Valentin Goede, Manuela Hoechstetter, Carsten Utoft Niemann, Caspar da Cunha-Bang, Arnon P Kater, Julie Dubois, Michael Gregor, Philipp Bernhard Staber, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Barbara Eichhorst, Kirsten Fischer, Michael Hallek
Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies. Blood 143 (25) (2024)
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann
It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia. Blood advances (2024)
Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Davide Rossi, Thierry Soussi, Boris Tichy, Arnon P Kater, Carsten Utoft Niemann, Frederic Davi, Gianluca Gaidano, Stephan Stilgenbauer, Richard Rosenquist, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia 38 (7) (2024)
Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Davide Rossi, Thierry Soussi, Boris Tichy, Arnon P Kater, Carsten Utoft Niemann, Frederic Davi, Gianluca Gaidano, Stephan Stilgenbauer, Richard Rosenquist, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia (2024)
Mehdi Parviz, Rudi Agius, Emelie Curovic Rotbain, Noomi Vainer, Kathrine Aarup, Carsten Utoft Niemann
Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning. Leukemia & lymphoma 65 (4) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Rudi Agius, Anders C Riis-Jensen, Bettina Wimmer, Caspar da Cunha-Bang, Daniel Dawson Murray, Christian Bjørn Poulsen, Marianne B Bertelsen, Berit Schwartz, Jens Dilling Lundgren, Henning Langberg, Carsten Utoft Niemann
Deployment and validation of the CLL treatment infection model adjoined to an EHR system. NPJ digital medicine 7 (1) (2024)
Tereza Faitová, Christian Brieghel, Frank Eriksson, Carsten Utoft Niemann
Mortality in patients with lymphoid malignancies and multiple myeloma was stable upon and during the COVID-19 pandemic: A population-based, nation-wide study. HemaSphere 8 (3) (2024)
Petra Langerbeins, Adam Giza, Sandra Robrecht, Paula Cramer, Julia von Tresckow, Othman Al-Sawaf, Anna Maria Fink, Moritz Fürstenau, Nadine Kutsch, Florian Simon, Valentin Goede, Manuela Hoechstetter, Carsten Utoft Niemann, Caspar da Cunha-Bang, Arnon P Kater, Julie Dubois, Michael Gregor, Philipp Bernhard Staber, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Barbara Eichhorst, Kirsten Fischer, Michael Hallek
Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies. Blood 143 (25) (2024)
Rudi Agius, Anders C Riis-Jensen, Bettina Wimmer, Caspar da Cunha-Bang, Daniel Dawson Murray, Christian Bjørn Poulsen, Marianne B Bertelsen, Berit Schwartz, Jens Dilling Lundgren, Henning Langberg, Carsten Utoft Niemann
Deployment and validation of the CLL treatment infection model adjoined to an EHR system. NPJ digital medicine 7 (1) (2024)
Rebecca Svanberg Teglgaard, Hanne Vibeke Hansen Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P Kater, Mark-David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Davide Rossi, Thierry Soussi, Boris Tichy, Arnon P Kater, Carsten Utoft Niemann, Frederic Davi, Gianluca Gaidano, Stephan Stilgenbauer, Richard Rosenquist, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia 38 (7) (2024)
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten Utoft Niemann
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia. Blood advances 8 (16) (2024)
Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas, Thomas Chatzikonstantinou, Eugen Tausch, Mark Catherwood, Davide Rossi, Thierry Soussi, Boris Tichy, Arnon P Kater, Carsten Utoft Niemann, Frederic Davi, Gianluca Gaidano, Stephan Stilgenbauer, Richard Rosenquist, Kostas Stamatopoulos, Paolo Ghia, Sarka Pospisilova
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update. Leukemia 38 (7) (2024)
Simon Husby, Morten Tulstrup, Mads Harsløf, Christian Nielsen, Eva Haastrup, Lene Hyldahl Ebbesen, Mette Klarskov Andersen, Maroulio Pertesi, Christian Brieghel, Carsten Utoft Niemann, Björn Nilsson, Agoston Gyula Szabo, Niels Frost Andersen, Niels Abildgaard, Annette Vangsted, Kirsten Grønbaek
Mosaic chromosomal alterations in hematopoietic cells and clinical outcomes in patients with multiple myeloma. Leukemia (2024)
Rebecca Svanberg Teglgaard, Hanne Vibeke Hansen Marquart, Hans Jakob Hartling, Jakob Thaning Bay, Caspar da Cunha-Bang, Christian Brieghel, Tereza Faitová, Lisbeth Enggaard, Arnon P Kater, Mark-David Levin, Sabina Kersting, Sisse Rye Ostrowski, Carsten Utoft Niemann
Improved Innate Immune Function in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Therapy in Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Mehdi Parviz, Rudi Agius, Emelie Curovic Rotbain, Noomi Vainer, Kathrine Aarup, Carsten Utoft Niemann
Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning. Leukemia & lymphoma 65 (4) (2024)
Florian Simon, Rudy Ligtvoet, Sandra Robrecht, Paula Cramer, Nadine Kutsch, Moritz Fürstenau, Valentin Goede, Julia von Tresckow, Petra Langerbeins, Anna-Maria Fink, Henriette Huber, Eugen Tausch, Christof Schneider, Clemens M Wendtner, Matthias Ritgen, Martin Dreyling, Lothar Müller, Lutz Jacobasch, Werner J Heinz, Ursula Vehling-Kaiser, Liliya Sivcheva, Sebastian Böttcher, Peter Dreger, Thomas Illmer, Michael Gregor, Philipp Bernhard Staber, Stephan Stilgenbauer, Carsten Utoft Niemann, Arnon P Kater, Kirsten Fischer, Barbara Eichhorst, Michael Hallek, Othman Al-Sawaf
Endpoint Surrogacy in First-Line Chronic Lymphocytic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances 8 (2) (2024)
Emil R Kyvsgaard, Caroline Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten Utoft Niemann, Kirsten Grønbaek, Martin Hutchings, Simon Husby
Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy. British journal of haematology (2023)
Rebecca Svanberg Teglgaard, Cameron MacPherson, Adrian G Zucco, Rudi Agius, Tereza Faitova, Michael Asger Andersen, Caspar da Cunha-Bang, Lars Klingen Gjaerde, Maria Elizabeth Engel Møller, Patrick Terrence Brooks, Birgitte Lindegaard, Adin Sejdic, Zitta Barrella Harboe, Anne Ortved Gang, Ditte Stampe Hersby, Christian Brieghel, Susanne Dam Nielsen, Daria Podlekareva, Annemette Hald, Jakob Thaning Bay, Hanne Vibeke Hansen Marquart, Jens Dilling Lundgren, Anne-Mette Lebech, Marie Helleberg, Carsten Utoft Niemann, Sisse Rye Ostrowski
Erratum: Author Correction: Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients. Communications medicine 3 (2023)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia (2023)
Karoline Kielbassa, Marco V Haselager, Danique J C Bax, Bianca F van Driel, Julie Dubois, Mark-David Levin, Sabina Kersting, Rebecka Svanberg, Carsten Utoft Niemann, Arnon P Kater, Eric Eldering
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation. Leukemia (2023)
Ilaria Del Giudice, Luca Vincenzo Cappelli, Julio Delgado, Carsten Utoft Niemann, Michael Asger Andersen, Emelie Hamotal Curovic Rotbain, Kathrine Aarup, Renata Walewska, Andrea Visentin, Marina Deodato, Anna Maria Frustaci, Chiara Cavalloni, Massimo Gentile, Mohamad A Yassin, Deepesh P Lad, Lydia Scarfò, Max Flogegard, Mattias Mattsson, Sara Raponi, Caterina Ilari, Irene Della Starza, Ester M Orlandi, Alessandra Tedeschi, Livio Trentin, Gianpietro Semenzato, Anna Guarini, Paolo Ghia, Emili Montserrat, Robin Foà
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature. British journal of haematology (2023)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia (2023)
Matilde Slot, Carsten Utoft Niemann, Lars Holger Ehlers, Emelie Curovic Rotbain
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naïve unfit CLL without TP53 aberrations. Blood advances (2023)
Carsten Utoft Niemann
BTK inhibitors: safety + efficacy = outcome. Blood 142 (8) (2023)
Carsten Utoft Niemann
Immediate COVID-19 treatment in CLL. Blood 141 (18) (2023)
Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna Lena Lena Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Othman Al-Sawaf, Karl-Anton Kreuzer, Anna Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Final analysis of the CLL2-GIVe trial (obinutuzumab, ibrutinib, and venetoclax) in untreated CLL with del(17p)/TP53mut. Blood (2023)
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppa, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood advances (2023)
Noomi Vainer, Kathrine Aarup, Michael Asger Andersen, Lise Wind-Hansen, Tine Nielsen, Henrik Frederiksen, Lisbeth Enggaard, Christian Bjørn Poulsen, Carsten Utoft Niemann, Emelie Curovic Rotbain
Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia. British journal of haematology (2023)
Othman Al-Sawaf, Rudy Ligtvoet, Sandra Robrecht, Janina Stumpf, Anna-Maria Fink, Eugen Tausch, Christof Schneider, Sebastian Boettcher, Martin Mikusko, Matthias Ritgen, Johannes Schetelig, Julia von Tresckow, Ursula Vehling-Kaiser, Tobias Gaska, Clemens Martin Wendtner, Bjoern Chapuy, Kirsten Fischer, Karl-Anton Kreuzer, Stephan Stilgenbauer, Philipp Bernhard Staber, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial. Nature medicine (2023)
Tahla Munir, Carol Moreno, Carolyn Owen, George Follows, Ohad Benjamini, Ann Janssens, Mark-David Levin, Anders Osterborg, Tadeusz Robak, Martin Simkovic, Don Stevens, Sergey Voloshin, Vladimir Vorobyev, Munci Yagci, Loic Ysebaert, Keqin Qi, Qianya Qi, Lori Parisi, Srimathi Srinivasan, Natasha Schuier, Kurt Baeten, Angela Howes, Donne Bennett Caces, Carsten Utoft Niemann, Arnon P Kater
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Moritz Fürstenau, Yvonne J Thus, Sandra Robrecht, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Julie Dubois, Julia von Tresckow, Michaela Patz, Michael Gregor, Patrick Thornton, Philipp Bernhard Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christof Schneider, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Noesslinger, Michael Baumann, Holger Hebart, Tobias Gaska, Josien Regelink, Ellen C Dompeling, Vesa Lindstrom, Gunnar Juliusson, Anouk Andrea Widmer, Jeroen S Goede, Neta Goldschmidt, Florian Simon, Nisha De Silva, Anna Maria Fink, Kirsten Fischer, Clemens-Martin Wendtner, Matthias Ritgen, Monika Brüggemann, Eugen Tausch, Marcel Spaargaren, Eric Eldering, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Karl-Anton Kreuzer, Arnon P Kater
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations. Blood (2023)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 37 (2) (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 37 (2) (2022)
Rebecca Svanberg Teglgaard, Cameron MacPherson, Adrian G Zucco, Rudi Agius, Tereza Faitova, Michael Asger Andersen, Caspar da Cunha-Bang, Lars Klingen Gjaerde, Maria Elizabeth Engel Møller, Patrick Terrence Brooks, Birgitte Lindegaard, Adin Sejdic, Anne Ortved Gang, Ditte Stampe Hersby, Christian Brieghel, Susanne Dam Nielsen, Daria Podlekareva, Annemette Hald, Jakob Thaning Bay, Hanne Vibeke Hansen Marquart, Jens Dilling Lundgren, Anne-Mette Lebech, Marie Helleberg, Carsten Utoft Niemann, Sisse Rye Ostrowski
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients. Communications medicine 2 (1) (2022)
Christian Brieghel, Veerle Galle, Rudi Agius, Caspar da Cunha-Bang, Michael Asger Andersen, Philip Vlummens, Mattias Mattsson, Richard Rosenquist, Karin E Smedby, Carmen D Herling, Jasmin Bahlo, Michael Hallek, Jens Dilling Lundgren, Fritz Offner, Carsten Utoft Niemann
Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? European journal of haematology 108 (5) (2022)
Carsten Utoft Niemann, Caspar da Cunha-Bang, Marie Helleberg, Sisse R Ostrowski, Christian Brieghel
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era. Blood 140 (5) (2022)
Henriette Huber, Simone Edenhofer, Julia von Tresckow, Sandra Robrecht, Can Zhang, Eugen Tausch, Christof Schneider, Johannes Bloehdorn, Moritz Fürstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna L Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Anna-Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Obinutuzumab (GA-101), ibrutinib, and venetoclax (GIVe) frontline treatment for high-risk chronic lymphocytic leukemia. Blood 139 (9) (2022)
Emelie Curovic Rotbain, Max J Gordon, Noomi Vainer, Henrik Frederiksen, Henrik Hjalgrim, Alexey V Danilov, Carsten Utoft Niemann
The CLL comorbidity index in a population-based cohort: a tool for clinical care and research. Blood advances 6 (8) (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 37 (2) (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 37 (2) (2022)
Paul J Hengeveld, Y Emre Ertem, Julie M N Dubois, Clemens H M Mellink, Anne-Marie van der Kevie-Kersemaekers, Ludo M Evers, Kim Heezen, P Martijn Kolijn, Olaf R F Mook, M Mahdi Motazacker, Kazem Nasserinejad, S Kersting, Peter E Westerweel, Carsten Utoft Niemann, Arnon P Kater, Anton W Langerak, Mark-David Levin
Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21 R110 . Leukemia 36 (7) (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia 37 (2) (2022)
Rebecca Svanberg Teglgaard, Cameron MacPherson, Adrian G Zucco, Rudi Agius, Tereza Faitova, Michael Asger Andersen, Caspar da Cunha-Bang, Lars Klingen Gjaerde, Maria Elizabeth Engel Møller, Patrick Terrence Brooks, Birgitte Lindegaard, Adin Sejdic, Anne Ortved Gang, Ditte Stampe Hersby, Christian Brieghel, Susanne Dam Nielsen, Daria Podlekareva, Annemette Hald, Jakob Thaning Bay, Hanne Vibeke Hansen Marquart, Jens Dilling Lundgren, Anne-Mette Lebech, Marie Helleberg, Carsten Utoft Niemann, Sisse Rye Ostrowski
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients. Communications medicine 2 (2022)
Simon Husby, Cecilie Bæch-Laursen, Christian W Eskelund, Francesco Favero, Jakob Schmidt Jespersen, Martin Hutchings, Lone Bredo Pedersen, Carsten Utoft Niemann, Joachim Weischenfeldt, Riikka Räty, Thomas Stauffer Larsen, Arne Kolstad, Mats Jerkeman, Kirsten Grønbaek
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL. Leukemia 36 (12) (2022)
Christian M Jensen, Junia C Costa, Jens C Nørgaard, Adrian G Zucco, Bastian Neesgaard, Carsten Utoft Niemann, Sisse Rye Ostrowski, Joanne Reekie, Birgit Holten, Anna Kalhauge, Michael A Matthay, Jens Dilling Lundgren, Marie Helleberg, Kasper S Moestrup
Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score. Scientific reports 12 (1) (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence N'Guyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia (2022)
Mehdi Parviz, Christian Brieghel, Rudi Agius, Carsten Utoft Niemann
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data. Blood advances 6 (12) (2022)
Emelie Curovic Rotbain, Caspar da Cunha-Bang, Christian Brieghel, Carsten Utoft Niemann
CLL-IPI applied in Binet A CLL: a nationwide cohort study. Blood advances 6 (21) (2022)
Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton, Georgios Karakatsoulis, Manja Meggendorfer, Helen Parker, Ferran Nadeu, Christian Brieghel, Stamatia Laidou, Riccardo Moia, Davide Rossi, Mark Catherwood, Jana Kotaskova, Julio Delgado, Ana Eugenia Rodríguez Vicente, Rocío Benito, Gian Matteo Rigolin, Silvia Bonfiglio, Lydia Scarfo, Mattias Mattsson, Zadie Davis, Ajay Gogia, Lata Rani, Panagiotis Baliakas, Hassan Foroughi-Asl, Cecilia Jylhä, Aron Skaftason, Inmaculada Rapado, Fatima Miras, Joaquín Martinez-Lopez, Javier de laSerna, Jesús María Hernández Rivas, Patrick Thornton, María José Larráyoz, María José Calasanz, Viktória Fésüs, Zoltán Mátrai, Csaba Bödör, Karin E Smedby, Blanca Espinet, Anna Puiggros, Ritu Gupta, Lars Bullinger, Francesc Bosch, Bárbara Tazón-Vega, Fanny Baran-Marszak, David Oscier, Florence Nguyen-Khac, Thorsten Zenz, Maria Jose Terol, Antonio Cuneo, María Hernández-Sánchez, Sarka Pospisilova, Kenneth Ian Mills, Gianluca Gaidano, Carsten Utoft Niemann, Elias Campo, Jonathan C Strefford, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia (2022)
Michael Asger Andersen, Mia Klinten Grand, Christian Brieghel, Volkert Siersma, Christen Lykkegaard Andersen, Carsten Utoft Niemann
Pre-diagnostic trajectories of lymphocytosis predict time to treatment and death in patients with chronic lymphocytic leukemia. Communications medicine 2 (2022)
Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David John Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko Antic, Mónica Baile, Panagiotis Baliakas, Dominique Bron, Antonella Capasso, Sofia Chatzileontiadou, Raul Cordoba, Juan-Gonzalo Correa, Carolina Cuéllar-García, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Christos Demosthenous, Maria Dimou, David Donaldson, Michael Doubek, Maria Efstathopoulou, Barbara Eichhorst, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Henrik Frederiksen, Moritz Fürstenau, Jose Antonio Garcia-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Andreas Glenthøj, Maria Gomes da Silva, Odit Gutwein, Yervand K Hakobyan, Yair Herishanu, Jose-Ángel Hernández-Rivas, Tobias Herold, Idanna Innocenti, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B Kalashnikova, Elżbieta Kalicińska, Linda Katharina Karlsson, Arnon P Kater, Sabina Kersting, Jorge Labrador-Gomez, Deepesh P Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Alberto López-García, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Mattias Mattsson, Francesca R Mauro, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Carsten Utoft Niemann, Raquel Nunes Rodrigues, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Kristian Qvist, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Gevorg Saghumyan, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Tamar Tadmor, Doreen Te Raa, Sanne H Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Roel van Kampen, Marzia Varettoni, Andrea Visentin, Candida Vitale, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Caterina Ilari, Antonio Cuneo, Kostas Stamatopoulos, Paolo Ghia
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia 35 (12) (2021)
Emelie Curovic Rotbain, Carsten Utoft Niemann, Klaus Rostgaard, Caspar da Cunha-Bang, Henrik Hjalgrim, Henrik Frederiksen
Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death. Leukemia 35 (9) (2021)
Caspar da Cunha-Bang, Nikolai S Kirkby, Lennart Friis-Hansen, Carsten Utoft Niemann
Serological response following vaccination with BNT162b2 mRNA in patients with chronic lymphocytic leukemia. Leukemia & lymphoma (2021)
Caspar da Cunha-Bang, Klaus Rostgaard, Michael A Andersen, Emelie C Rotbain, Kirsten Grønbaek, Henrik Frederiksen, Carsten Utoft Niemann, Henrik Hjalgrim
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study. British journal of haematology 193 (2) (2021)
Christian Brieghel, Kathrine Aarup, Mathias Husted Torp, Michael Asger Andersen, Christina W Yde, Xin Tian, Adrian Wiestner, Inhye E Ahn, Carsten Utoft Niemann
Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (16) (2021)
William G Wierda, Andrew Rawstron, Florence Cymbalista, Xavier Badoux, Davide Rossi, Jennifer R Brown, Alexander Egle, Virginia Abello, Eduardo Cervera Ceballos, Yair Herishanu, Stephen P Mulligan, Carsten Utoft Niemann, Colin P Diong, Teoman Soysal, Ritsuro Suzuki, Hoa T T Tran, Shang-Ju Wu, Carolyn Owen, Stephan Stilgenbauer, Paolo Ghia, Peter Hillmen
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations. Leukemia 35 (11) (2021)
Rudi Agius, Mehdi Parviz, Carsten Utoft Niemann
Artificial intelligence models in chronic lymphocytic leukemia - recommendations toward state-of-the-art. Leukemia & lymphoma (2021)
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Shamaila Munir Ahmad, Anne Ortved Gang, Evelina Martinenaite, Stine Emilie Weis-Banke, Marie Fredslund Breinholt, Guy Wayne Novotny, Julie Westerlin Kjeldsen, Morten Orebo Holmström, Lone Bredo Pedersen, Christian Bjørn Poulsen, Per Boye Hansen, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. Oncoimmunology 10 (1) (2021)
Fie Juhl Vojdeman, Jens Helby, Lone B Pedersen, Christian Brieghel, Michael Asger Andersen, Børge G Nordestgaard, Stig Egil Bojesen, Carsten Utoft Niemann
Chronic lymphocytic leukaemia clones are detectable decades before diagnosis. British journal of haematology (2021)
Emelie Curovic Rotbain, Klaus Rostgaard, Michael A Andersen, Caspar Da Cunha-Bang, Carsten Utoft Niemann, Henrik Frederiksen, Henrik Hjalgrim
Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia. Clinical epidemiology 13 (2021)
Uffe Klausen, Nicolai Grønne Dahlager Jørgensen, Jacob Handlos Grauslund, Shamaila Munir Ahmad, Anne Ortved Gang, Evelina Martinenaite, Stine Emilie Weis-Banke, Marie Fredslund Breinholt, Guy Wayne Novotny, Julie Westerlin Kjeldsen, Morten Orebo Holmström, Lone Bredo Pedersen, Christian Bjørn Poulsen, Per Boye Hansen, Özcan Met, Inge Marie Svane, Carsten Utoft Niemann, Lars Møller Pedersen, Mads Hald Andersen
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma. Oncoimmunology 10 (1) (2021)
Michael Asger Andersen, Klaus Rostgaard, Carsten Utoft Niemann, Henrik Hjalgrim
Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. Leukemia 35 (3) (2020)
Guðrun Jákupsdóttir Egholm, Michael Asger Andersen, Christen Lykkegaard Andersen, Henrik Frederiksen, Ole Weis Bjerrum, Carsten Utoft Niemann
Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival. British journal of haematology 192 (3) (2020)
Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin, Giulia Quaresmini, Marina Motta, Candida Vitale, Jose Antonio Garcia-Marco, Jose-Ángel Hernández-Rivas, Fatima Mirás, Mónica Baile, Juan Marquet, Carsten Utoft Niemann, Gianluigi Reda, Talha Munir, Eva Gimeno, Monia Marchetti, Francesca Maria Quaglia, Marzia Varettoni, Julio Delgado, Sunil Iyengar, Ann Janssens, Roberto Marasca, Angela Ferrari, Carolina Cuéllar-García, Gilad Itchaki, Martin Špaček, Lorenzo De Paoli, Luca Laurenti, Mark-David Levin, Enrico Lista, Francesca R Mauro, Martin Šimkovič, Ellen Van Der Spek, Elisabeth Vandenberghe, Livio Trentin, Ewa Wasik-Szczepanek, Rosa Ruchlemer, Dominique Bron, Maria Rosaria De Paolis, Giovanni Del Poeta, Lucia Farina, Myriam Foglietta, Massimo Gentile, Yair Herishanu, Tobias Herold, Ozren Jaksic, Arnon P Kater, Sabina Kersting, Lara Malerba, Lorella Orsucci, Viola Maria Popov, Paolo Sportoletti, Mohamed Yassin, Barbara Pocali, Gabor Barna, Annalisa Chiarenza, Gimena Dos Santos, Eugene Nikitin, Martin Andres, Maria Dimou, Michael Doubek, Alicia Enrico, Yervand Hakobyan, Olga Kalashnikova, Macarena Ortiz Pareja, Maria Papaioannou, Davide Rossi, Nimish Shah, Amit Shrestha, Oana Stanca, Niki Stavroyianni, Vladimir Strugov, Constantine Tam, Mihnea Zdrenghea, Marta Coscia, Kostas Stamatopoulos, Giuseppe Rossi, Alessandro Rambaldi, Emili' Montserrat, Caterina Ilari, Antonio Cuneo, Paolo Ghia
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia 34 (9) (2020)
Rudi Agius, Christian Brieghel, Michael Asger Andersen, Alexander T Pearson, Bruno Ledergerber, Alessandro Cozzi-Lepri, Yoram Louzoun, Christen L Andersen, Jacob Bergstedt, Jakob H von Stemann, Mette Jørgensen, Man-Hung Eric Tang, Magnus Fontes, Jasmin Bahlo, Carmen D Herling, Michael Hallek, Jens Dilling Lundgren, Cameron Ross MacPherson, Jan Larsen, Carsten Utoft Niemann
Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Nature communications 11 (1) (2020)
Moritz Fürstenau, Petra Langerbeins, Nisha De Silva, Anna Maria Fink, Sandra Robrecht, Julia von Tresckow, Florian Simon, Karin Hohloch, Jolanda Droogendijk, Marjolein van der Klift, Ellen van der Spek, Thomas Illmer, Björn Schöttker, Kirsten Fischer, Clemens-Martin Wendtner, Eugen Tausch, Stephan Stilgenbauer, Carsten Utoft Niemann, Michael Gregor, Arnon P Kater, Michael Hallek, Barbara Eichhorst
COVID-19 among fit patients with CLL treated with venetoclax-based combinations. Leukemia 34 (8) (2020)
Michael Asger Andersen, Rebecca Valentin, Lene Dissing Sjö, Line Borgwardt, Kjeld Schmiegelow, Mette Klarskov Andersen, Rasmus L Marvig, Christina Westmose Yde, Carsten Utoft Niemann
Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Acta oncologica (Stockholm, Sweden) 59 (12) (2020)
Rebecca Svanberg Teglgaard, Sisse Rye Ostrowski, Kazem Nasserinejad, Sabina Kersting, Johan A Dobber, Mattias Mattson, Hoa T T Tran, Mark-David Levin, Rogier Mous, Arnon P Kater, Carsten Utoft Niemann
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib. Leukemia & lymphoma 61 (14) (2020)
Caspar da Cunha-Bang, Carsten Utoft Niemann
Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies. Drugs 78 (16) (2019)
Abbey Elsbernd, Maiken Hjerming, Camilla Visler, Lisa Lyngsie Hjalgrim, Carsten Utoft Niemann, Kirsten Arntz Boisen, Jens Jakobsen, Helle Pappot
Using Cocreation in the Process of Designing a Smartphone App for Adolescents and Young Adults With Cancer: Prototype Development Study. JMIR formative research 2 (2) (2018)
Abbey Elsbernd, Maiken Hjerming, Camilla Visler, Lisa Lyngsie Hjalgrim, Carsten Utoft Niemann, Kirsten Arntz Boisen, Helle Pappot
Cocreated Smartphone App to Improve the Quality of Life of Adolescents and Young Adults with Cancer (Kræftværket): Protocol for a Quantitative and Qualitative Evaluation. JMIR research protocols 7 (5) (2018)

Carsten Utoft Niemann.css-eqlu8i{font-size:small;padding-left:4px;} (Carsten Niemann, Carsten U Niemann)

Publication Activity (10 Years)

Top Topics

Top Venues

Carsten Utoft Niemann (Carsten Niemann, Carsten U Niemann)